Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Drug Discovery Informatics Market Size to Grow USD 1 Million by 2030 at a CAGR of 9% | Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

10 Jun, 2024, 15:52 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, June 10, 2024 /PRNewswire/ -- Drug Discovery Informatics Market is Segmented by Type (Software, Services), by Application (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs)).

The Global Drug Discovery Informatics Market is anticipated to reach USD 1 Million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-14V4103/Global_Drug_Discovery_Informatics_Market

Major Factors Driving the Growth of Drug Discovery Informatics Market:

The desire for tailored treatment, growing investment in pharmaceutical R&D, and technological improvements are the main factors driving the growth of the Drug Discovery Informatics market. The use of machine learning and artificial intelligence in drug development procedures has greatly improved data processing skills and sped up the process of identifying possible therapeutic candidates. The administration and interpretation of enormous volumes of biological and chemical data is made easier by the rise in big data analytics and cloud computing, which propels market development even further. The market's strong growth is also attributed to regulatory backing and partnerships between pharmaceutical firms and informatics providers, which streamline and improve the efficacy of the drug development pipeline.

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-14V4103/global-drug-discovery-informatics

TRENDS INFLUENCING THE GROWTH OF THE DRUG DISCOVERY INFORMATICS MARKET

Because it simplifies and improves several phases of drug development, software employed by pharmaceutical and biotechnology businesses is a major factor driving the growth of the drug discovery informatics industry. By making it easier to handle and analyse large datasets, these cutting-edge software programs help researchers find possible medication candidates more rapidly and precisely. These technologies enhance target identification, lead optimization, and predictive modelling by combining AI, machine learning, and big data analytics, thereby speeding up the drug development process. They also provide improved platforms for cooperation, which provide improved data exchange and communication amongst research teams located in different places. This technology integration boosts the likelihood of successful outcomes while also cutting down on the time and expenses related to drug research, which drives the expansion of the drug discovery informatics field.

The market for drug discovery informatics is expanding at a substantial rate due to services utilized by Contract Research Organizations (CROs), which offer superior technology capabilities and specialized experience to improve the drug development process. Pharmaceutical and biotechnology businesses can outsource important parts of their research thanks to CROs' array of informatics services, which includes data administration, computer modelling, and bioinformatics analysis. Through outsourcing, these businesses may access state-of-the-art informatics tools and knowledge without having to make substantial internal investments. Through the utilisation of CROs' advanced data analytics and management skills, businesses may expedite their drug discovery timelines, enhance data precision, and optimise resource distribution. This partnership not only boosts the efficacy and efficiency of drug research initiatives, but it also raises demand for sophisticated informatics solutions.

The market for drug discovery informatics is also growing as a result of the emergence of precision medicine. Precision medicine seeks to customise medical care to each patient's unique attributes, including genetic composition, way of life, and surroundings. This method makes extensive use of informatics technologies to evaluate patient data and find tailored therapy solutions. In order to find biomarkers, comprehend genetic variances, and create tailored medicines that work better and have fewer adverse effects, drug discovery informatics is essential. The need for sophisticated informatics solutions that can support precision medicine initiatives is being driven by the growing emphasis on individualised treatment plans. Pharmaceutical sector transformation is being aided by drug discovery informatics, which facilitates the creation of more targeted and customised medicines.

Another important element driving the industry ahead is the growing use of machine learning (ML) and artificial intelligence (AI) in drug discovery. Large datasets can be analysed by AI and ML algorithms more rapidly and correctly than by traditional approaches, and they may spot patterns and links that human researchers would overlook. These technologies are very helpful in the early phases of drug development, such as target validation and identification, since they may be used to forecast the potential efficacy of novel therapeutic targets. Through the prediction of patient reactions and the identification of ideal dosage regimens, AI-driven systems may help optimise the design of clinical trials. This speeds up the entire drug development process and raises the success rates of clinical trials.

Buy Now: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-14V4103&lic=single-user

DRUG DISCOVERY INFORMATICS MARKET SHARE ANALYSIS

Because of its strong pharmaceutical sector, large R&D expenditures, and early adoption of cutting-edge technology, North America is a market leader in drug discovery informatics. Leading biotechnology corporations, pharmaceutical companies, and research institutes at the forefront of drug development are mostly located in the United States.

The area promotes the development and integration of cutting-edge informatics solutions with its strong emphasis on innovation and significant investment from both the public and commercial sectors. North America leads the world in drug discovery informatics due in part to the availability of a highly qualified labour force and strong partnerships between academia and business. Consequently, the area keeps witnessing noteworthy progressions in informatics instruments and technologies, augmenting the efficacy and efficiency.

Purchase Regional Report: https://reports.valuates.com/market-reports/QYRE-Auto-14V4103/global-drug-discovery-informatics/6

Key Companies:

  • IBM
  • INFOSYS LIMITED
  • Thermo Fisher Scientific
  • PerkinElmer Inc
  • Schrödinger
  • Charles River Laboratories
  • Selvita S.A
  • Certara
  • GVK Biosciences
  • Collaborative Drug Discovery
  • OpenEye Scientific Software
  • IO Informatics
  • Novo Informatics
  • Dassault
  • Dassault Systèmes

Purchase Chapters: https://reports.valuates.com/market-reports/QYRE-Auto-14V4103/global-drug-discovery-informatics/1 

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!

-  Drug Discovery Services market was valued at USD 17840 Million in 2023 and is anticipated to reach USD 34250 Million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.

-  Integrated Drug Discovery Service market is projected to reach USD 46260 Million in 2029, increasing from USD 18300 Million in 2022, with a CAGR of 13.8% during the period of 2023 to 2029.

-  Drug Screening market size is estimated to be worth USD 4567.1 Million in 2022 and is forecast to be a readjusted size of USD 6333.1 Million by 2028 with a CAGR of 5.6% during the review period.

-  Drug Detection and Analysis Market

-  Drug Excipients Market

-  Drug Discovery Technologies market was valued at USD 48000 Million in 2023 and is anticipated to reach USD 76370 Million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

-  Drug Filling Line Market

-  Pulmonary Drug Delivery Devices & Systems market was valued at USD 3046.1 Million in 2023 and is anticipated to reach USD 3966.6 Million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

-  Vaginitis Drug Market

-  Drug Contaminants Detection and Analysis Market

-  Virtual Drug Discovery Service Market

-  Cardiovascular Drug Market

-  Albinism Drug Market

-  Repurposed Drugs market was valued at USD 15260 Million in 2023 and is anticipated to reach USD 27320 Million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.

-  Valsartan Drug market was valued at USD 589 Million in 2023 and is anticipated to reach USD 866.2 Million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

-  Oxcarbazepine Drug market was valued at USD 432 Million in 2023 and is anticipated to reach USD 626.9 Million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

-  Lipid Lowering Drug Market

-  Anticoagulant Reversal Drug market was valued at USD 1444.8 Million in 2023 and is anticipated to reach USD 2259.5 Million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

-  Expectorant Drug market was valued at USD 325.6 Million in 2023 and is anticipated to reach USD 518.1 Million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.

-  Memory Enhancer Drugs Market

-  Anti-Tuberculosis Drug Market

-  Head Lice Drug market was valued at USD 987 Million in 2023 and is anticipated to reach USD 1483.8 Million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

-  Drugs of Abuse Testing Reagents Market

-  Aripiprazole Drug market was valued at USD 121 Million in 2023 and is anticipated to reach USD 167.1 Million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.

-  Drug Repurposing Service Market

-  Eye Drug Market

-  The therapeutic drug monitoring market was valued at D1,932.93 Million in 2021 and is projected to reach D4,415.3 Million by 2031, registering a CAGR of 8.5% from 2022 to 2031.

-  Drug Tests Services Market

-  MSD Drugs market was valued at USD 82410 Million in 2023 and is anticipated to reach USD 110750 Million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

-  Bulk Drug Market

-  Outsourced Drug Discovery market was valued at USD 17840 Million in 2023 and is anticipated to reach USD 34250 Million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.

-  Virtual Drug Discovery Service Market

-  Label-Free Drug Discovery Market

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

YOUR FEEDBACK MATTERS: REACH OUT TO US!

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
https://www.facebook.com/valuateskorean
https://www.facebook.com/valuatesspanish

https://www.facebook.com/valuatesjapanese

https://valuatesreportspanish.blogspot.com/

https://valuateskorean.blogspot.com/

https://valuatesgerman.blogspot.com/

https://valuatesreportjapanese.blogspot.com/

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

Modal title

Also from this source

Global Food Scanning Technology Market Set to Reach $2.16 Billion by 2030 with 7.3% CAGR | Valuates Reports

Global Food Scanning Technology Market Set to Reach $2.16 Billion by 2030 with 7.3% CAGR | Valuates Reports

Food Scanning Technology Market is Segmented by Type (Software, Scanning Device), by Application (Hotels and Restaurants, Food Testing Laboratories). ...

Sportswear Market to Reach $128.41 Billion by 2031, Driven by Health and Wellness Trend | Valuates Reports

Sportswear Market to Reach $128.41 Billion by 2031, Driven by Health and Wellness Trend | Valuates Reports

Sportswear Market is Segmented by Type (Hats, Upper Garment, Under Clothing, Skirts), by Application (Professional Athletic, Amateur Sport). The...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer & Electronics

Computer & Electronics

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.